Ted L. Underiner - Concepedia

Author

Ted L. Underiner

Avalon Pharma (United States)

Also Known As

Ted L. Underiner, Ted Underiner

Publications

944

Citations

H-Index

Concepts

All Affiliations

Avalon Pharma (United States)EKOS Corporation

About

Ted L. Underiner is an author at Avalon Pharma (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	327
2	Natural Sciences	11	12	338
3	Biochemistry	10	10	292
4	Biomolecular Engineering	9	9	235
5	Engineering	7	7	195

Ted L. Underiner

Publications

795

Citations

H-Index

Page 1

	Year	Citations
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells Weihua Wan, Mark S. Albom, Lihui Lü, Blood	2005	105
Diels-Alder approach to bicyclic .alpha.-hydroxy ketones. Facile ketol rearrangements of strained .alpha.-hydroxy ketones Xavier Creary, Pamela A. Inocencio, Ted L. Underiner, The Journal of Organic Chemistry Derivative (Chemistry).Alpha.-hydroxy KetonesHeterocyclicChemical AnalysisBiochemistry	1985	61
Designing Chemical Libraries for Lead Discovery Allan M. Ferguson, David E. Patterson, Cheryl D. Garr, SLAS DISCOVERY	1996	55
Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity Gregory R. Ott, Rabindranath Tripathy, Mangeng Cheng, ACS Medicinal Chemistry Letters Potent InhibitorKinase InhibitorsAnaplastic Lymphoma KinaseLead Inhibitor 15Tumor Biology	2010	49
Alkylation of allylic derivatives. 17. Cross-coupling reactions of diallylic pivalates with butyl- and phenylcopper reagents Ted L. Underiner, Harlan L. Goering The Journal of Organic Chemistry Derivative (Chemistry)Cross-coupling ReactionDerivativesEngineeringBiochemistry	1991	45
Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4<i>H</i>-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent Robert L. Hudkins, Nadine C. Becknell, Allison L. Zulli, Journal of Medicinal Chemistry PharmacotherapyTumor AngiogenesisTumor BiologyMolecular PharmacologyMedicinal Chemistry	2011	42
Alkylation of allylic derivatives. 14. Relationship of double-bond configuration between reactant and product for cross-coupling reactions of Z-allylic carboxylates with organocopper reagents Ted L. Underiner, Steven D. Paisley, Joel Schmitter, The Journal of Organic Chemistry Cross-coupling ReactionEngineeringAltmetric Attention ScoreOrganic ChemistryOrganocopper Reagents	1989	39
Stabilization demands of diethyl phosphonate substituted carbocations as revealed by substituent effects Xavier Creary, Ted L. Underiner The Journal of Organic Chemistry Chemical AnalysisDiethyl PhosphonateAltmetric Attention ScoreOrganic ChemistryChemistry	1985	36
First Synthesis of Cytotoxic 8,9-Secokaurene Diterpenoids. An Enantioselective Route to (−)-<i>O</i>-Methylshikoccin and (+)-<i>O</i>-Methylepoxyshikoccin Leo A. Paquette, Dirk Backhaus, Ralf J. Braun, Journal of the American Chemical Society Bioorganic ChemistryEnantioselective RouteEngineeringOrganic Chemistry8,9-Secokaurene Diterpenes	1997	32
Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase Karen L. Milkiewicz, Linda R. Weinberg, Mark S. Albom, Bioorganic & Medicinal Chemistry Pharmaceutical ChemistryMedicineSelective InhibitorsAnti-cancer AgentStructure–activity Relationships	2010	30

Page 1